Tweet
Does any body have paired end illumina data they are willing to share for the purposes of testing euler-sr? I'd prefer bacterial genomes, and am willing to sign any required non-disclosure agreements.
Thanks,
-mark
Thanks,
-mark
-
-
How about the K12 genome from CLC. It's provided for evaluation of their Genomics Workbench. They have Illumina (E. coli K12), ABI (S. suis) and Roche (E. coli K12) data sets. Click the link below saying "Alternatively, you can download the raw data here".
-
Thanks for the link... they are an interesting company.Originally posted by ScottC View Post
I should mention that I'm looking for anything but K12.Comment
-
theres about 300GB of paired end illumina data at NCBI - all Human.Comment
-
... more clarification ...
ideally bacterial or small fungal genomes. I'm working on de novo assembly, and my code isn't mature enough to handle the complicated mammalian repeat structure.Last edited by mchaisso; 07-06-2008, 09:55 PM.Comment
-
The NCBI short read archive might have some.
It certainly has some 454 FLX (paired) data, and some "Illumina GA" data for Bacteria, but unclear if it is paired.Comment
-
This is what Clive was talking about:
ftp://ftp.ncbi.nih.gov/pub/TraceDB/ShortRead/SRA000271/
40X human resequencing. All PE reads. They have been there for a month or so. (Sorry, not for bacteria...)Comment
-
Mark,
I know its not what you were asking for in this post, but if a set of 454 reads (~600k raw reads) would be useful for testing Euler-SR, I'd be happy to share those with you in exchange for a quick explanation of the output from this program
Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment